{"id":"W4406471500","doi":"10.1002/cac2.12661","title":"Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives","year":2025,"lang":"en","type":"article","venue":"Cancer Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Dosing; Pembrolizumab; Medicine; Medical physics; Psychology; Pharmacology; Internal medicine; Pharmacokinetics; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02404026,0.0007143203,0.002603413,0.0009497377,0.000277114,0.004604237,0.002230235,0.002599919,0.006245371],"category_scores_gemma":[0.03655877,0.0003573184,0.001383055,0.001491624,0.001630184,0.003074656,0.001044194,0.003226699,0.001000705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00186982,"about_ca_system_score_gemma":0.002686905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00126303,"about_ca_topic_score_gemma":0.001043889,"domain_scores_codex":[0.9891036,0.005665198,0.001028574,0.001590852,0.002370458,0.0002413684],"domain_scores_gemma":[0.9775056,0.01369209,0.003750059,0.00115104,0.003277717,0.0006234786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003853807,0.0007663562,0.005840306,0.003266017,0.0007143042,0.0001484942,0.0002510971,0.006149216,0.004273469,0.0115261,0.01279313,0.9504177],"study_design_scores_gemma":[0.002891179,0.02043715,0.03809504,0.01399,0.003905567,0.002948782,0.001550511,0.0690233,0.01899412,0.104261,0.7232954,0.0006079727],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04468534,0.8624517,0.04381081,0.03374355,0.001275216,0.0002984269,0.0008045479,0.0002310251,0.01269933],"genre_scores_gemma":[0.4909142,0.42872,0.04948616,0.01914806,0.005386149,0.0008992243,0.002048502,0.0003753094,0.003022324],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02404026,"threshold_uncertainty_score":0.1271386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03932492012326258,"score_gpt":0.4011608327392284,"score_spread":0.3618359126159658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}